Asymmetrical Smiles Corrected by Botulinum Toxin Serotype A

Benedetto, Anthony V.

doi:10.1111/j.1524-4725.2006.32329.x

Cited by 25 publications

(24 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…That is why the intradermal injection should be confined to the lateral part of the face to avoid unfavorable side effects. If those complications accidentally occur, they are temporary and reversible 7 …”

Section: Discussionmentioning

confidence: 99%

Midface lifting with botulinum toxin: intradermal technique

Petchngaovilai

2009

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Midface lifting with botulinum toxin: intradermal technique

Petchngaovilai

2009

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…32,55 The number of injection points and total dose should be decided on an individual patient basis. 32 …”

Section: Practical Aspects Of Abobotulinumtoxina Aesthetic Usementioning

confidence: 99%

The Practical Use of AbobotulinumtoxinA in Aesthetics

Kane¹,

Monheit

2017

Aesthetic Surgery Journal

View full text Add to dashboard Cite

Botulinum toxin (BoNT) has been approved for aesthetic use since 2002. Since then, clinical studies and expert use have informed our understanding of how BoNT exerts its clinical effect and the practical use of this product across a number of aesthetic applications. This review discusses the clinical properties and characteristics of abobotulinumtoxinA, which patients are suitable for its use, and how it can be utilized to treat facial rhytides.

show abstract

“…Other treatment areas include the mid-face (bunny lines, nasal flare, nasolabial folds) (47)(48)(49), the lower face (mouth frown, chin, deep smile lines, and masseter reduction) (47,50,51), and neck (47,52). Correction of asymmetry remains an important area in which BoNTA has proven effective (47,53).…”

Section: Additional Dermatologic Experiencementioning

confidence: 98%

The evolution of botulinum neurotoxin type A for cosmetic applications

Carruthers¹,

Carruthers

2007

Journal of Cosmetic and Laser Therapy

View full text Add to dashboard Cite

Very few pharmaceutical preparations share an evolutionary history as remarkable as that of botulinum neurotoxin (BoNT). The exotoxin of the organism Clostridium botulinum, once feared as a terrible poison, has been reborn as a highly regarded and widely used therapeutic and aesthetic agent. In less than two decades since the report of the success of BoNT type A (BoNTA) in reducing glabellar lines, injection of this product has become the most common non-surgical cosmetic procedure performed in the USA and worldwide. In addition to temporarily eliminating rhytids by muscle weakening, other dermatologic applications of BoNTA include correcting facial asymmetries and treating hyperhidrosis. Although BOTOX is the most clinically substantiated and published of the BoNTA preparations, other BoNTA products, as well as a BoNT type B product, are available in some parts of the world, and others are in development.

show abstract

Asymmetrical Smiles Corrected by Botulinum Toxin Serotype A

Abstract: BOTOX is an effective, safe, and long-lasting treatment for lower lip asymmetries caused by a hyperkinetic depressor labii inferioris.

Cited by 25 publications

References 8 publications

Midface lifting with botulinum toxin: intradermal technique

Midface lifting with botulinum toxin: intradermal technique

The Practical Use of AbobotulinumtoxinA in Aesthetics

The evolution of botulinum neurotoxin type A for cosmetic applications

Contact Info

Product

Resources

About